|
1
|
Villa-Forte A and Mandell BF:
Cardiovascular disorders and rheumatic disease. Rev Esp Cardiol.
64:809–817. 2011.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marijon E, Mirabel M, Celermajer DS and
Jouven X: Rheumatic heart disease. Lancet. 379:953–964. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li N, Lian J, Zhao S, Zheng D, Yang X,
Huang X, Shi X, Sun L, Zhou Q, Shi H, et al: Detection of
differentially expressed micrornas in rheumatic heart disease:
miR-1183 and miR-1299 as potential diagnostic biomarkers. Biomed
Res Int. 2015:5245192015.PubMed/NCBI
|
|
4
|
Lu H, Pan WZ, Wan Q, Cheng LL, Shu XH, Pan
CZ, Qian JY and Ge JB: Trends in the prevalence of heart diseases
over a ten-year period from single-center observations based on a
large echocardiographic database. J Zhejiang Univ Sci B. 17:54–59.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Victor S: Dilemmas in the management of
rheumatic heart disease. J Indian Med Assoc. 97:265–270.
1999.PubMed/NCBI
|
|
6
|
Sriharibabu M, Himabindu Y and Kabir Z:
Rheumatic heart disease in rural south India: A
clinico-observational study. J Cardiovasc Dis Res. 4:25–29. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Izikki M, Guignabert C, Fadel E, Humbert
M, Tu L, Zadigue P, Dartevelle P, Simonneau G, Adnot S, Maitre B,
et al: Endothelial-derived FGF2 contributes to the progression of
pulmonary hypertension in humans and rodents. J Clin Invest.
119:512–523. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y, Peng J, Lu C, Hsin M, Mura M, Wu
L, Chu L, Zamel R, Machuca T, Waddell T, et al: Metabolomic
heterogeneity of pulmonary arterial hypertension. PLoS One.
9:e887272014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiaoying C, Huadan Y, Qingxiao H, Annan Z,
Linlin T and Shiwei D: The effects of DNA methylation on the
homeostasis in vascular diseases. Yi Chuan. 37:221–232. 2015.(In
Chinese). PubMed/NCBI
|
|
10
|
Soubrier F, Chung WK, Machado R, Grünig E,
Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH and
Humbert M: Genetics and genomics of pulmonary arterial
hypertension. J Am Coll Cardiol. 62 25 Suppl:D13–D21. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JD, Lee A, Choi J, Park Y, Kang H,
Chang W, Lee MS and Kim J: Epigenetic modulation as a therapeutic
approach for pulmonary arterial hypertension. Exp Mol Med.
47:e1752015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pousada G, Baloira A and Valverde D:
Methylation analysis of the BMPR2 gene promoter region in patients
with pulmonary arterial hypertension. Arch Bronconeumol.
52:293–298. 2016.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saco TV, Parthasarathy PT, Cho Y, Lockey
RF and Kolliputi N: Role of epigenetics in pulmonary hypertension.
Am J Physiol Cell Physiol. 306:C1101–C1105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu R, Leslie KL and Martin KA: Epigenetic
regulation of smooth muscle cell plasticity. Biochim Biophys Acta.
1849:448–453. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ospelt C: Epigenetic biomarkers in
rheumatology-the future? Swiss Med Wkly. 146:w143122016.PubMed/NCBI
|
|
16
|
Plant D, Webster A, Nair N, Oliver J,
Smith SL, Eyre S, Hyrich KL, Wilson AG, Morgan AW, Isaacs JD, et
al: Differential methylation as a biomarker of response to
etanercept in patients with rheumatoid arthritis. Arthritis
Rheumatol. 68:1353–1360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zufferey F, Williams FM and Spector TD:
Epigenetics and methylation in the rheumatic diseases. Semin
Arthritis Rheum. 43:692–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu L, Zheng D, Wang L, Jiang D, Liu H, Xu
L, Liao Q, Zhang L, Liu P, Shi X, et al: GCK gene-body
hypomethylation is associated with the risk of coronary heart
disease. Biomed Res Int. 2014:1517232014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bibikova M, Le J, Barnes B,
Saedinia-Melnyk S, Zhou L, Shen R and Gunderson KL: Genome-wide DNA
methylation profiling using Infinium® assay. Epigenomics.
1:177–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bibikova M, Barnes B, Tsan C, Ho V,
Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et
al: High density DNA methylation array with single CpG site
resolution. Genomics. 98:288–295. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du P, Zhang X, Huang CC, Jafari N, Kibbe
WA, Hou L and Lin SM: Comparison of Beta-value and M-value methods
for quantifying methylation levels by microarray analysis. BMC
Bioinformatics. 11:5872010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bright PD, Mayosi BM and Martin WJ: An
immunological perspective on rheumatic heart disease pathogenesis:
More questions than answers. Heart. 102:1527–1532. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jeffries MA, Dozmorov M, Tang Y, Merrill
JT, Wren JD and Sawalha AH: Genome-wide DNA methylation patterns in
CD4+ T cells from patients with systemic lupus erythematosus.
Epigenetics. 6:593–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fernández-Tajes J, Soto-Hermida A,
Vázquez-Mosquera ME, Cortés-Pereira E, Mosquera A, Fernández-Moreno
M, Oreiro N, Fernández-López C, Fernández JL, Rego-Pérez I and
Blanco FJ: Genome-wide DNA methylation analysis of articular
chondrocytes reveals a cluster of osteoarthritic patients. Ann
Rheum Dis. 73:668–677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
de la Rica L, Urquiza JM, Gómez-Cabrero D,
Islam AB, López-Bigas N, Tegnér J, Toes RE and Ballestar E:
Identification of novel markers in rheumatoid arthritis through
integrated analysis of DNA methylation and microRNA expression. J
Autoimmun. 41:6–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Menzies V, Lyon DE, Archer KJ, Zhou Q,
Brumelle J, Jones KH, Gao G, York TP and Jackson-Cook C: Epigenetic
alterations and an increased frequency of micronuclei in women with
fibromyalgia. Nurs Res Pract. 2013:7957842013.PubMed/NCBI
|
|
27
|
Garcia JJ and Ortega E: Soluble
fractalkine in the plasma of fibromyalgia patients. An Acad Bras
Cienc. 86:1915–1917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Janssens K, Van den Haute C, Baekelandt V,
Lucas S, van Horssen J, Somers V, Van Wijmeersch B, Stinissen P,
Hendriks JJ, Slaets H and Hellings N: Leukemia inhibitory factor
tips the immune balance towards regulatory T cells in multiple
sclerosis. Brain Behav Immun. 45:180–188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thevenon J, Laurent G, Ader F, Laforêt P,
Klug D, Pentiah A Duva, Gouya L, Maurage CA, Kacet S, Eicher JC, et
al: High prevalence of arrhythmic and myocardial complications in
patients with cardiac glycogenosis due to PRKAG2 mutations.
Europace. pii:euw0672016.(Epub ahead of print). View Article : Google Scholar
|
|
30
|
Hedberg-Oldfors C and Oldfors A:
Polyglucosan storage myopathies. Mol Aspects Med. 46:85–100. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kidane YH, Lawrence C and Murali TM:
Computational approaches for discovery of common immunomodulators
in fungal infections: Towards broad-spectrum immunotherapeutic
interventions. BMC Microbiol. 13:2242013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stahl EA, Raychaudhuri S, Remmers EF, Xie
G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A,
et al: Genome-wide association study meta-analysis identifies seven
new rheumatoid arthritis risk loci. Nat Genet. 42:508–514. 2010.
View Article : Google Scholar : PubMed/NCBI
|
